Ling Ye

7.5k total citations · 2 hit papers
133 papers, 5.6k citations indexed

About

Ling Ye is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ling Ye has authored 133 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 27 papers in Epidemiology and 17 papers in Infectious Diseases. Recurrent topics in Ling Ye's work include HIV Research and Treatment (12 papers), Crystal structures of chemical compounds (8 papers) and RNA Interference and Gene Delivery (8 papers). Ling Ye is often cited by papers focused on HIV Research and Treatment (12 papers), Crystal structures of chemical compounds (8 papers) and RNA Interference and Gene Delivery (8 papers). Ling Ye collaborates with scholars based in China, United States and Singapore. Ling Ye's co-authors include Jian Q. Feng, Yuji Mishina, Stephen E. Harris, Chao Niu, Haiyang Huang, Jason Ross, Jiwang Zhang, Leanne M. Wiedemann, Linheng Li and Xi He and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ling Ye

123 papers receiving 5.5k citations

Hit Papers

Identification of the hae... 2003 2026 2010 2018 2003 2023 500 1000 1.5k 2.0k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ling Ye 2.1k 1.4k 942 921 815 133 5.6k
Hideaki Nakajima 3.1k 1.5× 1.4k 1.0× 1.2k 1.3× 1.6k 1.8× 929 1.1× 268 8.2k
Mario Petrini 1.4k 0.7× 976 0.7× 2.1k 2.2× 831 0.9× 1.5k 1.9× 319 7.2k
Hiroaki Honda 2.1k 1.0× 755 0.6× 610 0.6× 652 0.7× 388 0.5× 125 4.4k
Bernard Mari 4.3k 2.1× 437 0.3× 958 1.0× 1.1k 1.2× 328 0.4× 164 8.5k
Bryan Ronain Smith 2.4k 1.1× 851 0.6× 1.6k 1.6× 629 0.7× 165 0.2× 90 7.4k
Douglas A. Steeber 2.3k 1.1× 442 0.3× 1.3k 1.4× 4.1k 4.5× 200 0.2× 106 9.9k
Livingston Van De Water 4.5k 2.2× 575 0.4× 1.5k 1.6× 882 1.0× 443 0.5× 76 9.3k
Helen O. McCarthy 2.8k 1.4× 244 0.2× 709 0.8× 1.5k 1.6× 922 1.1× 243 10.4k
Masoud Soleimani 4.0k 1.9× 383 0.3× 589 0.6× 488 0.5× 2.2k 2.7× 422 9.4k
Gëorge F. Murphy 3.3k 1.6× 607 0.4× 3.4k 3.7× 3.1k 3.3× 628 0.8× 250 11.5k

Countries citing papers authored by Ling Ye

Since Specialization
Citations

This map shows the geographic impact of Ling Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Ye more than expected).

Fields of papers citing papers by Ling Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Ye. The network helps show where Ling Ye may publish in the future.

Co-authorship network of co-authors of Ling Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Ye. A scholar is included among the top collaborators of Ling Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Ye. Ling Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shuangjie, et al.. (2025). Coexistence of hepatitis B e antigen and antibody during antiviral treatment predicts better clinical outcomes in children. Journal of Pediatric Gastroenterology and Nutrition. 81(5). 1251–1259.
2.
Ye, Ling, et al.. (2025). HBcrAg Dynamic Change During Treatment Predicts HBsAg Loss in Pediatric Patients With Chronic Hepatitis B. Journal of Medical Virology. 97(4). e70350–e70350.
3.
Chen, Junfang, Zhou Sun, Sisheng Wu, et al.. (2025). Spatiotemporal dynamics of HIV-1 transmission networks in a major migration hub: integrated phylogenetic and molecular evidence. Frontiers in Microbiology. 16. 1682213–1682213.
5.
Gao, Lu, Yunjian Liu, Ling Ye, et al.. (2025). Metal ion coordinated tea polyphenol nanocoating for enhanced probiotic therapy in inflammatory bowel disease. Biomaterials. 321. 123323–123323. 11 indexed citations
6.
Sun, Zhou, et al.. (2024). Epidemiological dynamics and molecular characterization of HIV drug resistance in eastern China from 2020 to 2023. Frontiers in Microbiology. 15. 1475548–1475548. 4 indexed citations
7.
Lu, Man, et al.. (2024). The Gut Microbial Lipid Metabolite 14(15)-EpETE Inhibits Substance P Release by Targeting GCG/PKA Signaling to Relieve Cisplatin-Induced Nausea and Vomiting in Rats. Journal of Microbiology and Biotechnology. 34(9). 1769–1777. 1 indexed citations
8.
Zeng, Yingying, Xin Bai, Mengchan Zhu, et al.. (2024). m6A-mediated HDAC9 upregulation promotes particulate matter-induced airway inflammation via epigenetic control of DUSP9-MAPK axis and acts as an inhaled nanotherapeutic target. Journal of Hazardous Materials. 477. 135093–135093. 7 indexed citations
9.
Jun-fang, Chen, et al.. (2024). Exploring HIV-1 Transmission Features Among Older Individuals in Developed Eastern China. AIDS Research and Human Retroviruses. 40(9). 502–510.
10.
Zhang, Weiwei, Xin Jiang, X. D. Shi, et al.. (2022). RNAi Degrades Spike Protein Gene Transcripts of the SARS-CoV-2 for Developing Drugs to Treat of COVID-19. Nano Biomedicine and Engineering. 14(2). 1 indexed citations
11.
Kuang, Yun, Guoping Yang, Qi Pei, et al.. (2020). Effect of high-fat diet on the pharmacokinetics and safety of flumatinib in healthy Chinese subjects. Cancer Chemotherapy and Pharmacology. 86(3). 339–346. 4 indexed citations
12.
Liu, Yanan, Jie Huang, Shuang Yang, et al.. (2020). A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects. Cancer Chemotherapy and Pharmacology. 85(3). 555–562. 12 indexed citations
13.
Ye, Ling, Hua-Peng Chen, Hang Zhou, & Shengnan Wang. (2020). Dynamic response uncertainty analysis of vehicle-track coupling system with fuzzy variables. STRUCTURAL ENGINEERING AND MECHANICS. 75(4). 519–527. 1 indexed citations
14.
Hu, Yujie, et al.. (2018). Study on the efficiency of nursing service and the allocation of human resources in blood collection center based on visiting volume. ˜The œJournal of practical nursing. 34(23). 1819–1823.
16.
Ye, Ling. (2012). Analysis on Technology Application for Green Building and Revision Suggestions for Evaluation Standard for Green Building(GB/T 50378-2006). Building Science. 3 indexed citations
17.
Liu, Jing & Ling Ye. (2009). An aldose reductase inhibitor screening model constructed by transfection of pSNAV-AR into HEK293 cells. Zhongguo shengwu gongcheng zazhi. 29(9). 0–0. 1 indexed citations
18.
Ye, Ling. (2009). Construction and function study of a drug-screening model based on aldose reductase gene and its inhibitors. Zhongguo yaolixue tongbao. 1 indexed citations
19.
Bu, Zhigao, Ling Ye, Marianne J. Skeen, et al.. (2003). Enhancement of Immune Responses to an HIV env DNA Vaccine by a C-Terminal Segment of Listeriolysin O. AIDS Research and Human Retroviruses. 19(5). 409–420. 6 indexed citations
20.
Zhang, Jiwang, Chao Niu, Ling Ye, et al.. (2003). Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 425(6960). 836–841. 2251 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026